With ongoing disruptions affecting the availability of essential medical consumables, including intravenous supplies, wound care products, diagnostic kits, and personal protective equipment, health care systems are facing increasing operational strain. Shortages of these frontline supplies create delays, increase clinician workload, and compromise care delivery across hospitals, clinics, and community care settings.

Most importantly, supply disruptions pose a direct risk to patient safety and continuity of care. When critical consumables are unavailable, procedures may be postponed, infection risk may increase, and treatment quality can decline, placing both patients and clinicians under pressure.

Pharmacy supply chain disruptions directly shape the treatment that patients receive. That’s why it’s vital that pharmacists understand the causes and consequences of delays, as well as the solutions available and the role they can take during these crises.

Understanding the Root Causes of Supply Chain Disruptions

Building a reliable medical supply chain network begins by acknowledging the issues most threatening it, including globalized supply networks, expensive increased production, regulatory remediation delays, cold chain capacity issues, and minimal inventory.

Global manufacturing of medical consumables like gloves, syringes, wound dressing, and diagnostic components creates exposure to geopolitical instability, trade restrictions, and transportation disruptions. The COVID-19 pandemic demonstrated how reliance on overseas production can result in critical shortages across health care systems. Any time tensions arise in these regions or along their trade routes, they result in raw material shortages.^1,2

Many of the disruptions are the result of medical manufacturing systems that cannot expand their capacity to meet demand. If demand suddenly spikes due to a disease outbreak or a global pandemic, most manufacturers are not able to increase output accordingly because of the expense and a lack of financial motivation.³

Product halts and recalls due to regulatory issues can take months or years to resolve.⁴ The remediation process itself is slow, but manufacturers also play a role in not adequately ensuring that production is up to standard.

The importance of the cold chain in pharmaceutical supply chains caught global attention during the pandemic with temperature-sensitive medical products.⁵ The pandemic may have passed, but the issue of cold chain capacity has not. Effective cold chain management is critical for maintaining drug integrity across storage, handling, and transportation. Breaks in temperature control due to equipment failure, transportation delays, or inadequate monitoring can lead to significant losses in consumables’ availability and force supplies to be discarded before reaching patients.

Finally, it’s common for medical product manufacturers to operate on minimal back stock. Most use the just-in-time model of logistics, which involves manufacturing only what’s needed. The outcome of this is that when a shortage arises, there’s very little inventory to rely on while it is being addressed. This significantly exacerbates delays.⁶

The Hidden Toll: Long-Term Harm to Patients

Supply chain delays are primarily tracked in terms of financial losses. Reports will break down the cost of raw material shortages or a failed cold chain, not the long-term harm to patients.

But there is a hidden toll that needs to be acknowledged to better highlight the urgency of the situation. When essential medical consumables are delayed in the supply chain, it increases health risks as patients may be forced to delay treatment or seek lesser treatment options.⁷

The common argument during supply shortages and delays is that pharmacists simply need to prescribe alternatives. In practice, treatment substitutions come with their own risks and regulatory hurdles that again can lead to compromised patient outcomes.

The Pharmacist’s Expanded Role During Disruptions

During disruptions, it’s not the manufacturers or the logistics teams that have to answer to sick patients. That responsibility falls to pharmacists. Often tasked with coordinating with prescribers and suppliers to minimize care gaps, they’re also the ones faced with managing substitutions and ensuring that any associated risks are mitigated.⁸

Patient counseling has always been a fundamental part of a pharmacist’s job, but this expands during disruptions. Patients often experience anxiety over medication changes and need to be properly supported to accept the adjusted care and any new indications.

Building a More Resilient Future: Emerging Solutions to Supply Chain Disruptions

The scale of supply chain issues can make pharmacists feel powerless in the face of systemic failures. Certainly, some aspects can only be addressed through legislation and logistics improvements, but there are a few key solutions that pharmacists can enact to improve supply resilience and continuity of care:

Automated Inventory Systems: This technology can ensure that as soon as inventory levels drop below set thresholds, new orders go out. This reduces delays by reducing administrative burden. Some of these inventory systems also have predictive tools that allow pharmacists to get ahead of demand.

E-Prescribing and Electronic Health Records Integration: Integrated tools like these allow prescriptions to be shared in real time and make it easier for pharmacists to check patient history if a substitution is needed.

Collaborating and Communicating with Health Care Systems: By pooling data with nearby hospitals and participating in regional reporting systems, pharmacists can be a part of flagging potential shortages before they cause problems for patients. These networks can also ensure that if there is a delay, pharmacists have contacts to reach out to if medication is desperately needed for a patient.

Diversified Supplier Networks: Supplier delays need to be treated as an inevitability, not a possibility. Having diversified supplier networks ensures that if one supplier fails, there’s a backup at the ready.

Conclusion

Strengthening pharmacy supply chains is essential for ensuring that pharmacists on the front line can offer the best possible treatments to patients. Although many of the issues are systemic, by taking practical steps to improve inventory management, health care communication, and proactive planning, pharmacists can play a meaningful role in mitigating delays and their impact on patient care.

REFERENCES

1. Bown CP. How COVID-19 medical supply shortages led to extraordinary trade and industrial policy. Asian Econ Policy Rev. 2021;17(1):114-135. doi:10.1111/aepr.12359

2. Chowdhury P, Paul SK, Kaisar S, Moktadir MA. COVID-19 pandemic related supply chain studies: a systematic review. Transp Res E Logist Transp Rev. 2021;148:102271. doi:10.1016/j.tre.2021.102271

3. Cherif R, Hasanov F. Industrial policy against pandemics. Ind Corp Change. 2025;34(5):1029-1043. doi:10.1093/icc/dtab042

4. Ghijs S, Wynendaele E, de Spiegeleer B. The continuing challenge of drug recalls: insights from a ten-year FDA analysis. J Pharm Biomed Anal. 2024;249:116349. doi:10.1016/j.jpba.2024.116349

5. Pambudi NA, Sarifudin A, Gandidi IM, Romadhon R. Vaccine cold chain management and cold storage technology to address the challenges of vaccination programs. Energy Reports. 2021;8:955-972. doi:10.1016/j.egyr.2021.12.039

6. Shore C, Brown L, Hopp WJ, eds. Building Resilience into the Nation’s Medical Product Supply Chains. National Academies Press; 2022.

7. Beleche T, Adetunji O, Parasrampuria S, eds. Impact of Drug Shortages on Patients in the United States: A Case Study of Three Drugs. Office of the Assistant Secretary for Planning and Evaluation (ASPE); 2024.

8. Ammar MA, Tran LJ, McGill B, et al. Pharmacists’ leadership in a medication shortage response: illustrative examples from a health system response to the COVID-19 crisis. J Am Coll Clin Pharm. 2021;4(9):1134-1143. doi:10.1002/jac5.1443